Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanfer

Showing results (341-350 of 374) with videos related to

Pageof 38
Sort By:
Bone Marrow Transplantation|March 13, 2024
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary SyndromeS L Morris, B R Thomas, R Palanicawandar, et al.
Journal of Pharmaceutical Sciences|April 25, 2017
Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: EnalaprilRoger K Verbeeck, Isadore Kanfer, Raimar Löbenberg, et al.
The Journal of Cell Biology|April 23, 2021
VPS13D promotes peroxisome biogenesisHeather A Baldwin, Chunxin Wang, Gil Kanfer, et al.
Transplantation|April 1, 1977
Renal transplantation and immunological abnormalities in thrombotic microangiopathy of adults: report of 5 casesM Arias-Rodriguez, J D Sraer, O Kourilsky, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2019
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasiaM M Frijstein, C A R Lok, D Short, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|March 23, 2010
Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phaseJirí Pavlů, Andrea K Kew, Beatrice Taylor-Roberts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Pageof 38

Showing results (341-350 of 374) with videos related to

Sort By:
Pageof 38
Bone Marrow Transplantation|March 13, 2024
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary SyndromeS L Morris, B R Thomas, R Palanicawandar, et al.
Journal of Pharmaceutical Sciences|April 25, 2017
Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: EnalaprilRoger K Verbeeck, Isadore Kanfer, Raimar Löbenberg, et al.
The Journal of Cell Biology|April 23, 2021
VPS13D promotes peroxisome biogenesisHeather A Baldwin, Chunxin Wang, Gil Kanfer, et al.
Transplantation|April 1, 1977
Renal transplantation and immunological abnormalities in thrombotic microangiopathy of adults: report of 5 casesM Arias-Rodriguez, J D Sraer, O Kourilsky, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2019
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasiaM M Frijstein, C A R Lok, D Short, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Blood|March 23, 2010
Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phaseJirí Pavlů, Andrea K Kew, Beatrice Taylor-Roberts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2011
EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedureKatayoun Rezvani, Edward J Kanfer, David Marin, et al.
Pageof 38